Momat cream appearance. 0.1% 15g

Description

Composition
Active substance:
100 g of the preparation contains: mometasone furoate – 0.1 g ;.
Excipients:
Paraffin (white soft paraffin), white beeswax, propylene glycol monostearate, stearyl alcohol, cetomacrogol, propylene glycol, methyl parahydroxybenzoate, propyl parahydroxybenzoate, purified water.
Description:
Cream white.
Product form:
Cream for external use of 0.1%.
5 g or 15 g in the aluminum tube having a nozzle with a closed end with a lid having a cutting edge for puncturing.
Each tube together with instructions for use placed in a cardboard box.
Contraindications
Hypersensitivity to any component of the formulation or to the GCS;
Rosacea, perioral dermatitis;
Bacterial, viral (Herpes simplex, chickenpox, Herpes zoster) or fungal infection of the skin;
Tuberculosis, syphilis;
Post-vaccination reactions;
Pregnancy (treatment of large areas of skin, long-term care);
Lactation (used in large doses and / or for a long time).
Carefully
Applying to the skin of the face and intertriginous skin, the use of occlusive dressings, as well as the treatment of large areas of skin and / or long-term treatment (particularly in children).
Dosage
0.1%
Indications
Inflammation and itching dermatoses with measurable glucocorticosteroid therapy.
Interaction with other drugs
cream drug interaction studies Momat with other drugs have not been conducted.
Overdose
Symptoms: inhibition of function of the hypothalamic-pituitary-adrenal system, including secondary adrenal insufficiency.
Treatment: symptomatic, if necessary – electrolyte imbalance correction, removal of the drug (for long-term therapy – gradual elimination).
pharmachologic effect
Pharmacological group:
Glucocorticosteroids for local use.
Pharmacological properties:
Mometasone – synthetic glucocorticosteroid (GCS) having anti-inflammatory, antipruritic and antiexudative action. GCS induce isolation of proteins that inhibit phospholipase A2 and collectively known lipocortin which control the biosynthesis of inflammatory mediators such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid.
Pharmacokinetics:
Absorption cream Momat insignificant. After 8 hours after the single application on intact skin (without occlusive dressings) detected in the systemic circulation of about 0.4% of active compound. Mometasone extensively metabolized in the liver, kidneys displayed mainly in the small amount in the bile.
Pregnancy and breast-feeding
Safety of application of mometasone furoate during pregnancy and lactation has not been studied.
GCS cross the placental barrier. Avoid long-term treatment and the use of large doses during pregnancy due to the risk of negative impact on fetal development.
Corticosteroids are excreted in breast milk. In the case where it is assumed the use of corticosteroids at high doses and / or for a long time, discontinue breastfeeding.
Conditions of supply of pharmacies
By prescription.
side effects
Rarely – skin irritation and dryness, burning sensation, pruritus, folliculitis, hypertrichosis, acne, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, the accession of a secondary infection, the signs of skin atrophy, striae, miliaria. Less than 1% of the cases – the formation of papules, pustules.
When applying the external forms of corticosteroids for a long time and / or for the treatment of large areas of skin, or by using occlusive dressings, especially in children and teenagers, can have side effects characteristic of systemic corticosteroids, including adrenal insufficiency and Cushing’s syndrome.
special instructions
When applied to large areas of the skin for a long time, especially when using occlusive dressings may develop systemic corticosteroids. In view of this, patients should be observed for signs of suppression of the hypothalamic-pituitary-adrenal system and the development of Cushing’s syndrome.
Avoid getting the cream Momat eyes.
Propylene glycol, a part of the drug may cause irritation at the site of application. In such cases, discontinue use Momat cream and appropriate treatment.
Note that corticosteroids can change the manifestation of some skin diseases that can complicate diagnosis. In addition, use of corticosteroids may cause delays wound healing.
When long-term therapy of GCS sudden cessation of treatment can lead to rebound syndrome, which manifests itself in the form of dermatitis with intense redness and burning sensation. Therefore, after the long course of treatment abolition of the drug must be carried out gradually, e.g., switching to intermittent treatment regimen before it is completely stopped.
Pediatric use
Due to the fact that in children the value of the ratio of surface area and body weight greater than that of adults, children are at greater risk of suppression of the hypothalamic-pituitary-adrenal system and the development of Cushing’s syndrome in the application of any topical corticosteroids. Long-term corticosteroids treatment of children can lead to violations of their growth and development.
Children should receive the minimum dose sufficient to achieve the effect.
Storage conditions
In a dry, dark place at a temperature not higher than 25 ° C.
Do not freeze.
Keep out of the reach of children.
Dosing and Administration
Outwardly.
Momat thin layer of cream is applied to the affected skin once daily. The duration of treatment is determined by its efficacy and tolerability by the patient, presence and severity of side effects.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist